Metoclopramide hydrochloride and Myelopathy - a phase IV clinical study of FDA data


Myelopathy is found among people who take Metoclopramide hydrochloride, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Metoclopramide hydrochloride and have Myelopathy. It is created by eHealthMe based on reports of 7,486 people who have side effects when taking Metoclopramide hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 29, 2022

7,486 people reported to have side effects when taking Metoclopramide hydrochloride.
Among them, 7 people (0.09%) have Myelopathy.

What is Metoclopramide hydrochloride?

Metoclopramide hydrochloride has active ingredients of metoclopramide hydrochloride. It is often used in nausea. eHealthMe is studying from 7,640 Metoclopramide hydrochloride users for its effectiveness, alternative drugs and more.

What is Myelopathy?

Myelopathy (any neurologic deficit related to the spinal cord) is found to be associated with 728 drugs and 371 conditions by eHealthMe.

Number of Metoclopramide hydrochloride and Myelopathy reports submitted per year:

Could Metoclopramide hydrochloride cause Myelopathy?

Gender of people who have Myelopathy when taking Metoclopramide hydrochloride *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Myelopathy when taking Metoclopramide hydrochloride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Metoclopramide hydrochloride *:

  1. Ondansetron: 6 people, 85.71%
  2. Magnesium: 6 people, 85.71%
  3. Sulfamethoxazole: 2 people, 28.57%
  4. Acetylsalicylic Acid: 2 people, 28.57%
  5. Toradol: 1 person, 14.29%
  6. Proscar: 1 person, 14.29%
  7. Prevacid: 1 person, 14.29%
  8. Levaquin: 1 person, 14.29%
  9. Flomax: 1 person, 14.29%

Common side effects people have besides Myelopathy *:

  1. Spinal Cord Injury Thoracic (spinal cord injury at thoracic vertebrae region): 6 people, 85.71%
  2. Psychiatric Symptom: 5 people, 71.43%
  3. Urinary Tract Infection: 5 people, 71.43%
  4. Dysstasia (difficulty in standing): 5 people, 71.43%
  5. Fear Of Falling: 5 people, 71.43%
  6. Gait Disturbance: 5 people, 71.43%
  7. Infection: 5 people, 71.43%
  8. Malaise (a feeling of general discomfort or uneasiness): 5 people, 71.43%
  9. Mobility Decreased (ability to move is reduced): 5 people, 71.43%
  10. Numbness And Tingling (unusual prickling sensations): 5 people, 71.43%

Common conditions people have *:

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 85.71%

* Approximation only. Some reports may have incomplete information.

Do you take Metoclopramide hydrochloride and have Myelopathy?

Check whether Myelopathy is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Myelopathy and when was it recovered:

Expand to all the drugs that have ingredients of metoclopramide hydrochloride:

Alternative drugs to, pros and cons of Metoclopramide hydrochloride:

Common Metoclopramide hydrochloride side effects:

Browse all side effects of Metoclopramide hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Myelopathy treatments and more:

COVID vaccines that are related to Myelopathy:

Common drugs associated with Myelopathy:

All the drugs that are associated with Myelopathy:

Common conditions associated with Myelopathy:

All the conditions that are associated with Myelopathy:

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride (the active ingredients of Metoclopramide hydrochloride) and Metoclopramide hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: